Hasan Mirza

Barts Health NHS Trust — United Kingdom

Medicine · Health Sciences

13h-index780citations179works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(53), Cancer Genomics and Diagnostics(32), Epigenetics and DNA Methylation(26), Advanced Breast Cancer Therapies(19), Cancer Immunotherapy and Biomarkers(17)

Publications179 total

Assessing PARP trapping dynamics in ovarian cancer using a CRISPR-engineered FRET biosensor
Cell Reports Methods·2025Open Access
Figure 6 from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma
2025Open Access
Figure 2 from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma
2025Open Access
Figure 1 from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma
2025Open Access
Figure 4 from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma
2025Open Access
Figure 5 from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma
2025Open Access
Figure 3 from Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma
2025Open Access
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2025Open Access
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2025Open Access
Abstract A038: Monitoring PARP trapping in live ovarian cancer cells using a CRISPR-engineered FRET biosensor
Cancer Research·2025
British Association for Sexual Health and HIV National Guideline on the Management of Scabies in adults 2025
International Journal of STD & AIDS·2025· 5 citedOpen Access
Assessing PARP trapping dynamics in ovarian cancer using a CRISPR-engineered FRET biosensor
2025· 1 citedOpen Access
Autosomal Dominant Drusen: A Review
Journal of the Foundations of Ophthalmology·2025
High Grade Serous Ovarian Cancers With Brain Metastasis Are Strongly Enriched In BRCA1 And BRCA2 Mutations
International Journal of Gynecological Cancer·2025Open Access
Refsum Disease: An Overview
Journal of the Foundations of Ophthalmology·2025
Spatial transcriptomic analysis reveals significant differences in tumor microenvironment in HPV-dependent and HPV-independent vulvar squamous cell carcinoma
Gynecologic Oncology·2025· 2 citedOpen Access
Table S1 Antibodies from <i>PTEN</i> Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma
2024Open Access
Table S3 HMOX1-hi gene expression from <i>PTEN</i> Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma
2024Open Access
Table S2 Genes per cluster from <i>PTEN</i> Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma
2024Open Access
Supplementary Figure legends from <i>PTEN</i> Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma
2024Open Access
page 1 of 9Next →

Frequent Co-authors

Iain A. McNeish(25), Darren Ennis(21), Anita Grigoriadis(18), Andrew Tutt(16), James D. Brenton(14), Gaia Giannone(13), Zhao Cheng(13), Michelle Lockley(12), Christopher J. Lord(11), Philip Smith(11), Thomas Bradley(11), Lena Morrill Gavarró(11), Anna Piskorz(11), Florian Markowetz(11), Jonathan Krell(10), Chishimba Sokota(9), Laura A. Tookman(9), Maggie C.U. Cheang(8), Melinda L. Telli(8), Baljeet Kaur(8)